PURPOSE: To investigate the relevance of transforming growth factor-β (TGF-β) dynamics in
plasma for identification of patients at low risk for developing pneumonitis as a complication …

In many thoracic cancers, the radiation dose that can safely be delivered to the target volume
is limited by the tolerance dose of the surrounding lung tissue. It has been hypothesized …

Assessing therapy response of breast cancer bone metastases is challenging. In retrospective
studies, serial 18 F-FDG PET was predictive of time to skeletal-related events (tSRE) and …

Effective radiation treatment of thoracic tumors is often limited by radiosensitivity of surrounding
tissues. Several experimental studies have suggested variations in radiosensitivity of …

Purpose: To improve the cure rates of thoracic malignancies by radiation dose escalation,
very accurate insight is required in the dose delivery parameters that maximally spare normal …

Histone deacetylase inhibitors (HDACIs) may overcome endocrine resistance in estrogen
receptor–positive (ER+) metastatic breast cancer. We tested whether 18 F-fluoroestradiol PET …

Calibration and reproducibility of quantitative 18 F-FDG PET measures are essential for
adopting integral 18 F-FDG PET/CT biomarkers and response measures in multicenter clinical …

Purpose To investigate combined MRI and 18 F-FDG PET for assessing breast tumor
metabolism/perfusion mismatch and predicting pathological response and recurrence-free survival …

Purpose This study evaluated the ability of 18 F-Fluorodeoxyglucose (FDG) and 18 F-Fluorothymidine
(FLT) imaging with positron emission tomography (PET) to measure early …

Purpose Regorafenib is an oral multikinase inhibitor approved for the therapy of previously
treated metastatic colorectal carcinoma (mCRC). The aim of the present study was to analyze …